Q2 Earnings Forecast for BBIO Issued By HC Wainwright
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – HC Wainwright issued their Q2 2026 earnings estimates for BridgeBio Pharma in a report issued on Tuesday, April 15th. HC Wainwright analyst R. Selvaraju anticipates that the company will post earnings per share of ($0.77) for the quarter. HC Wainwright currently has a “Buy” rating and a […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – HC Wainwright issued their Q2 2026 earnings estimates for BridgeBio Pharma in a report issued on Tuesday, April 15th. HC Wainwright analyst R. Selvaraju anticipates that the company will post earnings per share of ($0.77) for the quarter. HC Wainwright currently has a “Buy” rating and a […]